A tool called Chest Pain Choice facilitates shared decision-making between physicians and patients with chest pain, improving patient knowledge and follow-up care options. The intervention reduced unnecessary testing and hospital admissions without adverse effects.
A recent clinical trial provides objective evidence of muscle-related side effects associated with statins. Evolocumab was found to be superior to ezetimibe in reducing low-density lipoprotein cholesterol levels. The study's findings have significant implications for treating patients with statin intolerance.
A new study by the Endocrine Society finds that children and teenagers taking ADHD stimulant medications may have lower bone density, a condition that can increase fracture risk or osteoporosis later in adulthood. The study suggests that these patients may need monitoring of their bone health during treatment.
A new study suggests that a combined vaccine therapy using live Salmonella is safe and effective in preventing diabetes in mice. The vaccine works by rebalancing the immune system and preventing the attack on insulin-producing cells. Researchers believe this targeted immunotherapy has great potential for treating type 1 diabetes.
Research discovered that individuals with coronary artery disease exhibit higher baseline troponin levels independently of stress or chest pain, indicating repeated ischemic events. Mental stress tests revealed a significant increase in troponin levels, even after the event, suggesting psychological triggers play a role
A large clinical trial of evacetrapib, a CETP inhibitor, showed no reduction in major adverse cardiovascular events, despite significant increases in HDL and decreases in LDL cholesterol levels. The study's findings challenge conventional thinking on the benefits of high-density lipoprotein (HDL) cholesterol.
A new study from Intermountain Medical Center Heart Institute shows that testosterone supplementation reduced major adverse cardiovascular events in elderly men with low testosterone levels and pre-existing coronary artery disease. The study found that patients receiving testosterone therapy had a lower risk of heart attacks, strokes, ...
Research suggests that combining aromatase inhibitors with growth hormone can effectively and safely increase height in very short adolescent boys. The study found significant gains in height and lean body mass when using this combination therapy.
A new study reveals that only 1.02% of eligible patients receive weight loss medications, highlighting a significant gap between guidelines and treatment practices.
A technology-based competition increased daily physical activity levels by over 3,500 steps per day and led to significant weight loss. The study, which involved over 68,000 participants from 64 countries, found improvements in exercise frequency, sitting time reduction, and overall health.
The Society of Interventional Radiology honored two research papers for their impact on patient care. Dong Il Gwon's study validated a rapid PARTO procedure for treating gastric varices, while Ron C. Gaba's research explored gene expression in hepatocellular carcinoma for improved treatment outcomes.
Researchers compared one-year outcomes of SAPIEN 3 TAVR and open-heart surgery in patients with severe, symptomatic aortic stenosis. Patients who underwent TAVR had better mortality and stroke rates compared to those who received open-heart surgery.
A large clinical trial found that ischemic postconditioning did not reduce death from any cause or hospitalization for heart failure in STEMI patients, but improved left ventricular ejection fraction in a specific subgroup.
A study found that only 2% of people with very high cholesterol have a familial hypercholesterolemia mutation, but those with the mutation face a six times higher risk of early-onset coronary artery disease. Genetic screening could help identify and ward off cardiovascular disease in affected individuals.
A new minimally invasive weight loss treatment called bariatric arterial embolization has shown safety and efficacy in a clinical trial, initiating weight loss and reducing hunger levels. The procedure targets the production of ghrelin, a hormone controlling hunger, with promising results in sustaining weight loss.
Researchers identified ezetimibe and evolocumab as effective alternatives for patients with muscle-related statin intolerance, demonstrating significant reductions in LDL-C levels. The study suggests that both drugs can be administered successfully in such patients, although with varying efficacy.
Researchers found that SSRI antidepressants cause decreased bone density in mothers during lactation, leading to higher risks of fractures. Folic acid supplementation may mitigate this effect, suggesting women may need more folic acid while breast-feeding.
A safe, minimally invasive treatment called bariatric arterial embolization (BAE) has been shown to lead to sustained weight loss in severely obese people. BAE targets the stomach's hunger hormone production, reducing appetite and resulting in significant weight loss.
Intermediate-risk patients who received TAVR with SAPIEN 3 had improved outcomes compared to surgical aortic valve replacement after one year. The trial showed reduced rates of death, stroke, and moderate or severe aortic insufficiency in TAVR patients.
The DANAMI-3-DEFER trial found that delayed stent implantation in STEMI patients did not reduce death from any cause, hospitalization for heart failure, or subsequent heart attacks. The study's findings contradict previous promising preliminary studies and may be due to the trial's limited sample size and patient selection.
A new study found that abaloparatide-SC increased bone mineral density in the spine and hip, reducing the risk of vertebral and nonvertebral fractures. The treatment also showed promise in a broad range of postmenopausal women with osteoporosis, regardless of baseline patient characteristics.
Researchers found that intravenous beta blockers before angioplasty in STEMI patients did not reduce heart attack severity or improve blood flow, according to the EARLY-BAMI trial. The study showed a slight decrease in ventricular arrhythmias but no significant differences in other endpoints.
A new study suggests that taking antibiotics in early childhood may disrupt the gut's microbial ecosystem and increase the risk of developing prediabetes in adolescence. The researchers found that a depletion of beneficial bacteria, such as Ruminococcus species, was associated with higher rates of antibiotic use.
A study found that familial hypercholesterolemia mutations account for less than 2% of cases with severely elevated LDL levels, but significantly increase the risk of coronary artery disease. Gene sequencing identified individuals at high risk who may benefit from additional preventive therapies.
Renan Uflacker received the Society of Interventional Radiology Foundation's Leaders in Innovation Award for his pioneering work in interventional radiology. The award recognized his contributions to transforming the field through innovative treatments for liver disease, peripheral vascular disease and aneurysms.
A new study by the Cleveland Clinic has identified statin intolerance objectively, showing that evolocumab is a more effective option for lowering cholesterol in patients who are intolerant to multiple statins. The PCSK9 inhibitor reduced cholesterol levels by 52.8%, while ezetimibe had a smaller reduction of 16.7%.
In a clinical trial of 100 obese men, researchers found that adding testosterone treatment to calorie restriction resulted in increased fat loss and preserved muscle mass. The study suggests that testosterone treatment may be a useful adjunct to weight loss in obese men with low testosterone levels.
A phase 3 clinical trial showed evacetrapib reduced LDL cholesterol by 37% and HDL cholesterol by 130%, but failed to lower rates of major cardiovascular events. Researchers attribute the lack of benefits to the drug's inability to translate improved cholesterol levels into clinical outcomes.
Researchers from the University of Pennsylvania found that heart transplants can be performed in adult patients with prior corrective surgery for congenital heart disease with excellent outcomes. The study, which included 17 consecutive patients, showed a 100% survival rate at both 30 days and one year.
Women who underwent uterine fibroid embolization reported improved sexual function, including pain, desire, arousal, and satisfaction. About nine in 10 women also experienced a better overall quality of life, with average scores increasing from 45 to 71 one year after treatment.
Patients who received a physician discussion using Chest Pain Choice increased their knowledge about their risk and options, answering 53% of questions correctly. The study also found that patients who used the tool were more likely to recommend discussing their care with their physicians, 68.9% compared to 61.2%.
A higher volume of TAVR procedures is associated with improved patient outcomes, including lower death rates and vascular complications. The study, which analyzed data from nearly 50,000 patients, found that even hospitals performing fewer than 100 cases showed significant improvements in patient outcomes with higher procedure volumes.